Logo do repositório
 
Publicação

Mining viral proteins for antimicrobial and cell-penetrating drug delivery peptides

dc.contributor.authorFreire, João Miguel
dc.contributor.authorDias, Susana Almeida
dc.contributor.authorFlores, Luís
dc.contributor.authorVeiga, Ana Salomé
dc.contributor.authorCastanho, Miguel A. R. B.
dc.date.accessioned2016-03-18T15:01:49Z
dc.date.available2016-03-18T15:01:49Z
dc.date.issued2015
dc.description© The Author (2015). Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.compt_PT
dc.descriptionSupplementary data are available at http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv131/-/DC1pt_PT
dc.description.abstractMotivation: The need for more effective and safer pharmaceuticals is a persistent quest. Microbial adaptations create the need to permanently develop new antimicrobials, for instance. Similarly, intracellular delivery of drugs is still a challenge and translocation of membranes for drug delivery is an area of intense research. Peptides can be used both as antimicrobial drug leads and drug carrier systems for intracellular delivery. Multifunctional proteins are abundant in viruses but, surprisingly, have never been thoroughly screened for bioactive peptide sequences. Results: Using the AMPA and CellPPD online tools we have evaluated the propensity of viral proteins to comprise antimicrobial (AMP) or cell-penetrating peptides (CPP). Capsid proteins from both enveloped and non-enveloped viruses, and membrane and envelope proteins from enveloped viruses, in a total of 272 proteins from 133 viruses, were screened to detect the presence of potential AMP and CPP sequences. A pool of 2444 and 426 CPP and AMP sequences, respectively, were discovered. The capsids of flaviviruses are the best sources of these peptides reaching more than 80% of CPP sequence coverage per protein. Selected sequences were tested experimentally and validated the results. Overall, this study reveals that viruses form a natural multivalent biotechnological platform still underexplored in drug discovery and the heterogeneous abundance of CPP/AMP sequences among viral families opens new avenues in viral biology research.pt_PT
dc.description.sponsorshipJMF and ASV acknowledge FCT-MEC for PhD fellowship SFRH/BD/70423/2010 and fellowship F/00803/2012 under the FCT Investigator Programme. Funding: Fundação para a Ciência e Tecnologia – Ministério da Educação e Ciência (FCT-MEC, Portugal) [HIVERA/0002/2013].pt_PT
dc.identifier.citationBioinformatics (2015) , 31 (14): 2252-2256pt_PT
dc.identifier.doi10.1093/bioinformatics/btv131pt_PT
dc.identifier.issn1367-4803
dc.identifier.urihttp://hdl.handle.net/10451/23081
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherOxford University Presspt_PT
dc.relation.publisherversionhttp://bioinformatics.oxfordjournals.org/pt_PT
dc.titleMining viral proteins for antimicrobial and cell-penetrating drug delivery peptidespt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH/BD/70423/2010/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/3599-PPCDT/HIVERA%2F0002%2F2013/PT
oaire.citation.titleBioinformaticspt_PT
oaire.fundingStreamSFRH
oaire.fundingStream3599-PPCDT
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsclosedAccesspt_PT
rcaap.typearticlept_PT
relation.isProjectOfPublication5ed17e15-93b0-4a17-971c-e222c3f43117
relation.isProjectOfPublicationf992a355-2673-47ed-9b17-13d4e6cd4d88
relation.isProjectOfPublication.latestForDiscovery5ed17e15-93b0-4a17-971c-e222c3f43117

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
Bioinformatics_CPP.pdf
Tamanho:
192.13 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: